GE Healthcare and the American College of Cardiology Join Forces to Advance AI in Cardiac Care

CHICAGO (June 3, 2021) – GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s Applied Health Innovation Consortium for the purpose of building a roadmap for Artificial Intelligence (AI) and digital technology in cardiology and developing new strategies for improved health outcomes. The Consortium brings... Read more

Thermo Fisher Scientific Accelerates Complex Materials Research at Monash University with Specialized 300kV (S)TEM Microscope

Thermo Fisher Scientific Accelerates Complex Materials Research at Monash University with Specialized 300kV (S)TEM Microscope HILLSBORO, Ore., May 20, 2021 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, has developed a custom-built high-resolution scanning transmission electron microscope ((S)TEM) to support advanced materials research at Monash University. The instrument is being installed in the... Read more

Thermo Fisher Scientific and University of California, San Francisco to Open Cell Therapy cGMP Manufacturing and Collaboration Center

Thermo Fisher Scientific and University of California, San Francisco to Open Cell Therapy cGMP Manufacturing and Collaboration Center New facility will provide end-to-end solution to accelerate cell therapy development and manufacturing WALTHAM, Mass. and SAN FRANCISCO, May 19, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of... Read more

Ultra-high-field MRI Combines Forces with Artificial Intelligence: AIR Recon DL receives FDA 510(k) clearance on SIGNA 7.0T

Industry-first, deep learning image reconstruction technology, AIR Recon DL, now available on entire GE MR portfolio, including SIGNA 7.0T scanner Waukesha, WI – May 13, 2021 – Ahead of this year’s virtual ISMRM meeting, GE Healthcare is excited to announce that AIR Recon DL, the industry’s first deep learning image reconstruction technology that works across... Read more

Canada’s FortisBC Energy Selects Xylem for Advanced Gas Network

One million Sonix IQ meters to help increase safety and reliability in 20-year technology and services agreement RYE BROOK, N.Y.–(BUSINESS WIRE)–May 12, 2021– Xylem Inc. (NYSE: XYL), a leading global water and resource management technology company, is working with FortisBC Energy Inc. in British Columbia to deploy a Sensus advanced gas meter network. FortisBC serves... Read more

US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for previously untreated metastatic bladder cancer

Basel, 28 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 10 to 1 in favour of maintaining accelerated approval of Tecentriq® (atezolizumab) for the treatment of adults with locally advanced or metastatic urothelial carcinoma (mUC, bladder cancer) who are... Read more

Xylem, Esri Partnership Pairs Global Leaders In Water Technology And GIS To Help Utilities Worldwide Streamline Data And Insight

Xylem Becomes Platinum Esri Partner, Will Create Joint Solutions, Collaborate On Marketing Water Operators To Benefit From Better Network Visibility, Optimized Infrastructure, Lower Costs RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 28, 2021– Xylem (NYSE:XYL), a leading water technology company dedicated to solving the world’s greatest water challenges, has forged a partnership with Esri, the global leader in... Read more

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society

Thermo Fisher Scientific Recognizes Significance of FDA Approval of First CAR T Cell Immunotherapy for Multiple Myeloma with Donation to Leukemia and Lymphoma Society WALTHAM, Mass. (April 28, 2021) — Thermo Fisher Scientific Inc. has made a donation to the Leukemia & Lymphoma Society in recognition of the recent U.S. Food and Drug Administration approval... Read more